Colon cancer during pregnancy

被引:31
作者
Cappell, MS
机构
[1] Woodhull Med Ctr, Dept Med, Div Gastroenterol, Brooklyn, NY 11206 USA
[2] Suny Downstate Med Sch, Dept Med, Div Gastroenterol, Brooklyn, NY 11203 USA
关键词
D O I
10.1016/S0889-8553(02)00066-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colon cancer in pregnancy is a distinct entity from colon cancer in the general population. Pregnancy affects the clinical presentation, evaluation, therapy, and prognosis of the colon cancer. Pregnant patients typically present with advanced colon cancer that is, unfortunately, usually the result of delayed diagnosis. Patients frequently postpone self-referral because of confusion of symptoms from cancer, such as rectal bleeding or constipation, with symptoms of a normal pregnancy. Physicians may delay diagnostic tests because of potential fetal risks and because of inattention to the potential significance of symptoms given the relative rarity of colon cancer in this young population. Diagnostic delays often lead to the tragic demise of a young woman from a potentially curable disease and of an otherwise viable fetus. Arguably, colon cancer should be diagnosed expeditiously during pregnancy because of frequent obstetric office visits. This article reviews this uncommon, but not rare, entity with a focus on the special and unique features of colon cancer in pregnancy to facilitate earlier diagnosis, to optimize the therapy, and to improve the maternal and fetal outcomes.
引用
收藏
页码:341 / +
页数:44
相关论文
共 337 条
[1]   WEIGHT-GAIN AND ENERGY-INTAKE DURING PREGNANCY [J].
ABRAMS, B .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1994, 37 (03) :515-527
[2]  
Ahlquist D A, 1997, Gastrointest Endosc Clin N Am, V7, P439
[3]   Fecal occult blood testing for colorectal cancer - Can we afford to do this? [J].
Ahlquist, DA .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1997, 26 (01) :41-&
[4]   Molecular stool screening for colorectal cancer - Using DNA markers may be beneficial, but large scale evaluation is needed [J].
Ahlquist, DA .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7256) :254-255
[5]   Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel [J].
Ahlquist, DA ;
Skoletsky, JE ;
Boynton, KA ;
Harrington, JJ ;
Mahoney, DW ;
Pierceall, WE ;
Thibodeau, SN ;
Shuber, AP .
GASTROENTEROLOGY, 2000, 119 (05) :1219-1227
[6]   Stool screening for colorectal cancer: evolution from occult blood to molecular markers [J].
Ahlquist, DA ;
Shuber, AP .
CLINICA CHIMICA ACTA, 2002, 315 (1-2) :157-168
[7]  
ALLEN AC, 1994, CAN MED ASSOC J, V151, P547
[8]   NUTRITIONAL SUPPLEMENTATION FOR THE PREGNANT WOMAN [J].
ALLEN, LH .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1994, 37 (03) :587-595
[9]   A comparison of fecal occult-blood tests for colorectal-cancer screening [J].
Allison, JE ;
Tekawa, IS ;
Ransom, LJ ;
Adrain, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :155-159
[10]  
*AM HOSP FORM SERV, 1997, DRUG INF 1997, P2809